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Abstract
Background: Assessment health literacy in people with cardiovascular health problems would facilitate the
development of appropriate health strategies for the care and reduction of complications associated with oral
anticoagulation therapy. Aim: To evaluate the relationship between health literacy and health and treatment
outcomes (concordance with oral anticoagulants, Normalized Ratio control and occurrence of complications) in
patients with cardiovascular pathology.
Methods: Observational, analytic and cross-sectional study carried out on 252 patients with cardiovascular
pathology (atrial fibrillation, flutter or valve prosthesis), aged 50–85 years, accessing primary care services in Valencia
(Spain) in 2018–2019. Variables referring to anticoagulant treatment with vitamin K antagonists (years of treatment,
adequate control, polypharmacy and occurrence of complications, among others) and health literacy (Health
Literacy Questionnaire) were analysed.
Results: All dimensions of health literacy were significantly related to the level of education (p < 0.02), social class
(p < 0.02), an adequate control of acenocoumarol (p < 0.001), frequentation of health services (p < 0.001),
information by patients to health professionals about anticoagulant treatment (p < 0.03), emergency care visits (p <
0.001) and unscheduled hospital admissions (p < 0.001).
Conclusion: Health literacy has a relevant influence on the adequate self-management of anticoagulation
treatment and the frequency of complications. The different dimensions that comprise health literacy play an
important role, but the “social health support” dimension seems to be essential for such optimal self-management.
Trial registration: ACC-ACE-2016-01. Registration date: December 2015.
Keywords: Health literacy, Anticoagulants, Acenocoumarol, Treatment adherence and compliance, Self-
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Background
Cardiovascular diseases are the leading cause of death world-
wide. Atrial fibrillation (AF) is the most frequent arrhythmia,
associated with high mortality and morbidity [1], and with
an estimated prevalence in Spain of over 4.4%. Therapeutic
management of AF requires modification of cardiovascular
risk factors and use of drugs [1, 2] such as oral anticoagu-
lants (OAC). Among these, both vitamin K antagonists
(VKAs) and direct oral anticoagulants (DOACs) are effective
in preventing embolic events [2]. Because the anticoagulant
effect of DOACs is difficult to quantify, continuous monitor-
ing and education are necessary to ensure therapeutic
follow-up, reflecting the complexity of DOACs use [3, 4].
The recommendations for switching from VKAs to
DOACs due to the suboptimal control of the international
normalized ratio (INR) were eased in Spain in 2012. At
present, however, the legal requirement for a visa and the
high financial cost of DOACs prescribing make it difficult to
obtain widespread access for patients [5]. For such reasons,
VKAs continue to be the most frequently used OAC in
Spain, despite the need for routine blood tests and an exquis-
ite clinical control [6]. Further, it is vital that patients demon-
strate adequate self-care, along with treatment concordance
and sufficient knowledge to avoid or mitigate adverse effects,
to maintain the effectiveness of this treatment.
With these requirements in place, health literacy (HL)
could be an essential factor for the self-management of
anticoagulation treatment, in line with other cardiovas-
cular diseases [7]. Conceptually, HL encompasses differ-
ent aspects such as empowerment, as well as
competencies to understand, evaluate and use health in-
formation to make decisions, including the use of health
services [8]. Some preliminary studies exploring the ef-
fect of HL on awareness about AF and medication con-
cordance have demonstrated that people with
inadequate or insufficient levels of HL have poorer
health outcomes, have less knowledge about their health
problems and diseases, use preventive services less, and
suffer from higher mortality [9, 10].
So far, HL has been linked to the health conditions
and outcomes of people with cardiovascular disease.
Therefore, we believe that effective self-care, adherence
to treatment with oral anticoagulants and prevention of
complications could be directly related to the level of
health literacy.
However, the existing literature has directly associated
higher levels of HL with greater knowledge of the dis-
ease, but the association among HL, adherence to anti-
coagulant therapy and the occurrence of adverse events
has presented highly variable results and studies have
been scarce [11].
Because of this, we propose identifying the level of HL
in the local population on anticoagulation treatment and
exploring the relationship between HL and several
health and clinical outcomes. In addition, our work will
provide information about the relationship between the
different dimensions that make up HL, including the
social dimension as a novel aspect, and compliance with




Observational, analytic and cross-sectional study.
Population
We focused on 6 areas within the Xàtiva/Ontinyent
Health Department (Valencia, Spain), which were ran-
domly selected from the 17 areas of the department
(chose 6 numbers at random, choosing the areas that
corresponded with the number extracted). During the
study period (January 1, 2018 to April 30, 2019), all pa-
tients who came to the nursing consultation were invited
to fill out the HL questionnaire. For a population of N =
730 patients (data provided by the health department’s
pharmacy service), the smallest representative sample we
calculated is 252 patients (confidence level 95%, margin
of error 5%, population proportion 50%). Recruitment
ended after reaching the minimum representative study
sample (because the questionnaire was long, with com-
plex questions and patients in many cases refused to stay
and wait 15–20min more in the health centre).
The eligibility criteria were: Patients who are between
50 and 85 years old, have cardiovascular disease, mainly
arrhythmias (atrial fibrillation or flutter) or valvular dis-
ease, and have received VKAs treatment for at least 6
months. Exclusion criteria included vision or hearing
impairment that prevented the completion of the HL
questionnaire, illiteracy, discontinued treatment with
VKAs, severe neurocognitive or mental health problems
that prevented the patient from understanding their
pathological conditions, and finally patients whose treat-
ment with VKAs was administered by another person.
Methods of selection of participants were to offer par-
ticipation in the study to all patients who came to the
nursing consultation (both on a scheduled and on de-
mand) and met the selection criteria.
The study was conducted in rural areas with a popula-
tion of 2300 to 8000 inhabitants in each primary health
care center, where the distance to the health care center
is usually short and can be reached on foot by most
citizens.
Study assessment parameters
Data were obtained on the following variables:
– Socio-demographic: Age, sex, educational level
(without studies/basic education/university
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education) and self-perceived social class (low/
medium/high).
– Clinical: Main diagnosis, obesity (BMI > 30), high
blood pressure (HBP), polypharmacy (prescription
≥5 drugs), tobacco use (non-smoker/smoker) and
occurrence of complications (emergency care or
unscheduled hospital admissions during the previous
six months).
– VKA treatment: Years of treatment, reporting of
VKA treatment by patients to other health
professionals, number of controls in 6 months,
control of VKA treatment [good control if ~ 65%
INR measurements within range, with measurement
by direct method, for at least 6 months] [1, 2]
– HL: The Health Literacy Questionnaire (HLQ) [12]
was used to assess the level of HL. This
questionnaire assesses 9 different dimensions,
consists of 44 items and has been validated for
Spanish speakers.
– Dimension 1 (D1): Feeling understood and
supported by health care providers.
– Dimension 2 (D2): Having enough information to
manage my health.
– Dimension 3 (D3) Actively managing my health.
– Dimension 4 (D4) Social health support.
– Dimension 5 (D5) Assessment of health information.
– Dimension 6 (D6) Ability to actively participate with
health care providers.
– Dimension 7 (D7) Navigation through the health
system.
– Dimension 8 (D8) Ability to find good health
information.
– Dimension 9 (D9) Understanding health information
well enough to know what to do.
The scores for dimensions 1 to 5 are set to four values
(completely disagree/disagree/agree/strongly agree), and
the scores for dimensions 6 to 9 are set to 5 values (can-
not be done or always have difficulties/usually difficult/
Sometimes difficult/ usually have ease/ always have
ease). According to the author’s request, an independent
score was established for each dimension [13].
Sociodemographic variables were collected by means
of a patient interview, while clinical variables and those
referring to anticoagulant treatment with VKA were col-
lected from the medical records and prescriptions. With
regard to the health literacy variable, the questionnaire
was administered to patients by means of a direct inter-
view with the principal investigator.
Statistical analysis
To analyse quantitative variables were used central ten-
dency and dispersion measures. Absolute and relative
frequencies, expressed in percentages, were used for
qualitative variables. Parametric and non-parametric
tests were performed to evaluate the relationship be-
tween different variables and dimensions of HLQ. The
statistical significance level was determined to be p <
0.05. Were analysed all data using SPSS Statistics for
Windows (version 23, Spanish, Armonk, NY, IBM).
Ethical considerations
The study was approved by the Ethics and Clinical
Research Committee of the Primary Care Region of
Valencia (Ref.ACC-ACE-2016-01). All participants
have provided their written consent to participate in
the study and the data of the patients included in the
study have been anonymized at all times.
Results
Description of the sample
The response rate was 35% (252 patients responded to
the questionnaire). The average age was 74.3 +/− 7.3
years, with ~ 90% over 65-years old. Forty-two percent
were women, and 74.9% had AF as primary diagnosis.
With respect to their educational level, 50% of partici-
pants had basic studies, while 40.1% did not. Of the 252
participants, 49.2% had complications and 11.9%
required hospital admission (Table 1).
Relationships between HL dimensions and variables
The average score of the participants on each HL di-
mension was slightly higher than expected (average of
the scale) in all dimensions (Table 2), but mainly in di-
mension D4. The relationship between the HL dimen-
sions and the different study variables is presented in
Tables 3 and 4.
The ANOVA calculations of the different HL dimen-
sions according to the level of studies were statistically
significant, indicating differences in scores between two
or more of the study level groups. The results showed
that D2, D3, D5, D6, D7, D8 and D9 had differences be-
tween the three study level groups. The “without stud-
ies” group obtained the lowest mean scores on all
dimensions, in contrast to the “university education”
group with higher means.
For social class, all Kruskal-Wallis tests of the differ-
ent HL dimensions were statistically significant (p < .05)
implying differences in scores between two or more so-
cial class groups. Dimensions D5, D8 and D9, were ex-
plained by social class at 13–17%, suggesting a large
social class effect on these dimensions. D5 and D9
showed differences between all social class groups, with
lower median scores for lower-class than middle-class
participants. In turn, the median scores in the middle
class group were lower than those obtained by partici-
pants from the higher socioeconomic stratum.
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For variables related to medication use, there were sta-
tistically significant differences for “reports taking aceno-
coumarol” in all HL dimensions and for “polypharmacy”
in all dimensions except D1, D4 and D6 (Table 3). Non-
polymedicated participants and those reporting treatment
with VKA had higher mean scores on all dimensions.
Regarding the control of acenocoumarol and fre-
quency of controls, statistically significant differences
were obtained in all dimensions of the questionnaire. In
all cases, participants with good anticoagulant control
and adequate frequency obtained higher averages than
those without good control or suboptimal control fre-
quency. Additionally, the analysis indicated a small effect
for the control of acenocoumarol and the frequency of
controls on D4 scores. An average effect on the D1
scores for VKA control and on the D1 and D6 dimen-
sions for proper control frequency is shown. Finally,
there was a large effect on the scores of the other HL
dimensions for drug control and control frequency
(Table 4).
In relation to cardiovascular disease risk factors, to-
bacco use and HBP showed no statistically significant
differences (p > .05) on any dimension. In contrast, sta-
tistically significant differences in the D5, D8 and D9 di-
mensions were observed in obese participants, with
lower mean scores for these participants.
The occurrence of complications presented (p < .05)
in the scores of all dimensions of the HL questionnaire.
In all cases, the scores of patients without complications
were higher (Table 4). The same was true for emer-
gency department attendance in the previous 6
months. In both cases, a very large effect size was shown
in all HL dimensions except D1, D4 and D6.
Finally, hospital admissions showed statistically sig-
nificant differences (p < .05) in all dimensions for un-
scheduled hospitalizations in the previous 6months,
except in dimension D4. In all cases, the mean scores of
patients with unscheduled hospital admissions were
lower than in the rest of the patients (Table 4).
Discussion
In our study in patients with cardiovascular path-
ology, health literacy actively influenced the adequate
self-management of anticoagulation treatment, the ap-
pearance of complications and the unscheduled use of
health services. Patients with higher scores on HL
Table 1 Characteristics of participants (n = 252)
M/n Sd/ %
Age 74.38 7.35
< 65 years 26 10.3%
= > 65 years 226 89.7%
Sex Woman 107 42.5%
Man 145 57.5%
Education Level Without Studies 101 40.1%
Basic Education 126 50.0%
Higher Education 25 9.9%
Social Class Low 33 13.1%
Middle 206 81.7%
High 13 5.2%
Main Diagnosis Atrial Fibrillation 188 74.9%
Atrial Flutter 7 2.8%
Aortic Prosthesis 33 13.1%
Mitral Prosthesis 23 9.2%
Years of treatment 7.6 6.79
Good control of acenocoumarol No 114 45,2%
Yes 138 54,8%
Appearance of complications No 128 50.8%
Yes 124 49.2%
Emergency assistance last 6 months No 129 51.2%
Yes 123 48.8%
Hospital admission last 6 months No 222 88.1%
Yes 30 11.9%
Polypharmacy No 86 34.1%
Yes 166 65.9%
M Mean, n number of cases, Sd Standard deviation; %, percentage
Table 2 Average score of HL dimensions
Dimension Mean Standard error of the mean Standard deviation Median Maximum Minimum 25 Percentile 75 Percentile
Dimension 1 3.201 .027 .429 3.125 4.000 1.500 3.000 3.500
Dimension 2 2.657 .033 .517 2.750 4.000 1.000 2.250 3.000
Dimension 3 2.817 .032 .511 2.800 4.000 1.000 2.600 3.000
Dimension 4 3.494 .028 .437 3.600 4.000 1.400 3.200 3.800
Dimension 5 2.387 .043 .686 2.400 4.000 1.000 2.000 2.800
Dimension 6 4.106 .038 .596 4.200 5.000 1.200 3.800 4.600
Dimension 7 3.507 .041 .654 3.667 5.000 1.167 3.083 4.000
Dimension 8 3.052 .054 .851 3.200 5.000 1.000 2.400 3.800
Dimension 9 3.268 .055 .871 3.400 5.000 1.400 2.600 4.000
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dimensions had better control of OAC treatment and
optimal frequency of visits. They also reported confi-
dence about their information management skills, em-
powerment, and self-efficacy, presenting better self-
care. These results coincide with those demonstrated
by some authors [14–17].
Therapeutic concordance with OACs was significantly
related to the scores of all HL dimensions, with 54.8% of
participants presenting an adequate control of OAC
treatment. These results are similar to another study
carried out in Valencia [18], where 53.9% presented
good control, and slightly higher than the 47.5% of pa-
tients in Time in Therapeutic Range (TTR) in Granada
[19]. Reading et al. [20] related inadequate HL to a lack
of pharmacological adherence in AF, while another study
associated a poor control of VKA (TTR < 50%) with lim-
ited HL, especially in patients over 65 [21]. However,
other studies have reported equivocal relations between
HL and treatment adherence; for example, HL as mea-
sured with the S-TOFHLA scale was associated with
Table 3 Relationship and statistical significance between variables and HL dimensions
D1 D2 D3 D4 D5 D6 D7 D8 D9
Age D Sig. .022 −.105 −.104 −.030 −.223** −.118 −.189* −.282** −.261**
< 65 years Mean (SD) 3.18 (0.4) 2.73 (0.47) 2.86 (0.58) 3.48 (0.33) 2.59 (0.78) 4.35 (0.49) 3.74 (0.58) 3.42 (0.76) 3.59 (0.85)
Median (IQR) 3.13 (0.50) 2.75 (0.50) 3.00 (0.80) 3.40 (0.60) 2.60 (1.20) 4.40 (1.00) 3.83 (0.67) 3.50 (1.20) 3.80 (1.60)
= > 65 years Mean (SD) 3.2 (0.43) 2.65 (0.52) 2.81 (0.5) 3.5 (0.45) 2.36 (0.67) 4.08 (0.6) 3.48 (0.66) 3.01 (0.85) 3.23 (0.87)
Median (IQR) 3.13 (0.50) 2.75 (0.75) 2.80 (0.40) 3.60 (0.60) 2.40 (0.80) 4.20 (0.60) 3.50 (1.00) 3.00 (1.20) 3.40 (1.60)
Sex A Sig. .496 .055 .298 .137 .096 .217 .142 028* .015*
Woman Mean (SD) 3.18 (0.46) 2.58 (0.54) 2.78 (0.53) 3.44 (0.5) 2.3 (0.7) 4.05 (0.64) 3.44 (0.66) 2.92 (0.84) 3.11 (0.85)
Median (IQR) 3.00 (0.50) 2.50 (0.75) 2.80 (0.40) 3.60 (0.60) 2.40 (1.00) 4.00 (1.00) 3.50 (1.00) 3.00 (1.40) 3.20 (1.40)
Man Mean (SD) 3.22 (0.4) 2.71 (0.5) 2.85 (0.5) 3.53 (0.38) 2.45 (0.67) 4.15 (0.56) 3.56 (0.65) 3.15 (0.85) 3.38 (0.87)
Median (IQR) 3.25 (0.50) 2.75 (0.75) 2.80 (0.60) 3.60 (0.40) 2.40 (0.80) 4.20 (0.80) 3.67 (0.83) 3.20 (1.20) 3.40 (1.40)
Education Level B,C Sig. < .001** < .001** < .001** .016* < .001** < .001** < .001** < .001** < .001**
Without Studies Mean (SD) 3.06 (0.4) 2.33 (0.43) 2.51 (0.45) 3.42 (0.41) 1.94 (0.54) 3.85 (0.60) 3.08 (0.54) 2.38 (0.57) 2.56 (0.58)
Median (IQR) 3.00 (0.25) 2.25 (0.5) 2.60 (0.60) 3.60 (0.60) 2.00 (0.80) 4.00 (0.60) 3.17 (0.83) 2.40 (0.80) 2.40 (0.80)
Basic Education Mean (SD) 3.28 (0.44) 2.83 (0.47) 2.96 (0.42) 3.52 (0.47) 2.58 (0.56) 4.23 (0.53) 3.72 (0.57) 3.39 (0.66) 3.62 (0.67)
Median (IQR) 3.25 (0.50) 3.00 (0.5) 3.00 (0.40) 3.80 (0.40) 2.60 (0.60) 4.20 (0.60) 3.83 (0.50) 3.60 (1.00) 3.80 (0.60)
Higher Education Mean (SD) 3.4 (0.36) 3.11 (0.32) 3.36 (0.39) 3.67 (0.26) 3.26 (0.56) 4.54 (0.49) 4.16 (0.42) 4.06 (0.63) 4.35 (0.49)
Median (IQR) 3.25 (0.50) 3.00 (0.25) 3.20 (0.80) 3.80 (0.20) 3.20 (1.00) 4.60 (0.60) 4.00 (0.33) 4.00 (0.80) 4.40 (0.60)
Social Class C Sig. .019* < .001** < .001** .003* < .001** < .001** < .001** < .001** < .001**
Low Mean (SD) 2.98 (0.44) 2.3 (0.39) 2.41 (0.53) 3.38 (0.39) 1.81 (0.55) 3.76 (0.56) 3.04 (0.58) 2.25 (0.64) 2.43 (0.61)
Median (IQR) 3.00 (0.50) 2.25 (0.50) 2.4 (0.80) 3.40 (0.40) 1.80 (0.80) 3.80 (0.80) 3.00 (0.67) 2.20 (0.40) 2.20 (0.80)
Middle Mean (SD) 3.23 (0.42) 2.71 (0.51) 2.87 (0.49) 3.5 (0.45) 2.45 (0.66) 4.15 (0.59) 3.56 (0.65) 3.14 (0.82) 3.35 (0.83)
Median (IQR) 3.25 (0.50) 2.75 (0.75) 3.00 (0.60) 3.60 (0.60) 2.60 (0.80) 4.20 (0.80) 3.67 (0.83) 3.20 (1.20) 3.40 (1.40)
High Mean (SD) 3.27 (0.33 2.77 (0.5) 3 (0.34) 3.72 (0.29) 2.88 (0.67) 4.34 (0.51) 3.91 (0.31) 3.66 (0.64) 4.10 (0.56)
Median (IQR) 3.25 (0.50) 2.75 (0.25) 3.00 (0.20) 3.80 (0.0) 3.00 (0.40) 4.20 (0.60) 4.00 (0.17) 4.00 (0.80) 4.20 (0.20)
Polypharmacy A Sig. .255 < .001** .005* .780 < .001** .367 .004* < .001** < .001**
No Mean (SD) 3.24 (0.4) 2.82 (0.46) 2.94 (0.58) 3.48 (0.4) 2.62 (0.68) 4.15 (0.63) 3.67 (0.64) 3.4 (0.83) 3.58 (0.84)
Median (IQR) 3.25 (0.50) 3.00 (0.50) 3.00 (0.40) 3.60 (0.60) 2.60 (0.60) 4.20 (0.80) 3.83 (0.50) 3.60 (1.20) 3.80 (1.00)
Yes Mean (SD) 3.18 (0.44) 2.57 (0.53) 2.75 (0.46) 3.5 (0.46) 2.26 (0.66) 4.08 (0.58) 3.42 (0.65) 2.87 (0.81) 3.10 (0.84)
Median (IQR) 3.00 (0.50) 2.50 (0.75) 2.80 (0.40) 3.60 (0.60) 2.40 (1.00) 4.10 (0.60) 3.33 (0.83) 2.80 (1.40) 3.10 (1.40)
Obesity A Sig. .895 .288 .113 .525 .030* .318 .142 .030* .018*
No Mean (SD) 3.2 (0.43) 2.69 (0.52) 2.86 (0.51) 3.48 (0.45) 2.46 (0.7) 4.14 (0.55) 3.56 (0.65) 3.15 (0.84) 3.38 (0.86)
Median (IQR) 3.13 (0.50) 2.75 (0.75) 2.80 (0.60) 3.60 (0.60) 2.60 (1.00) 4.20 (0.80) 3.67 (0.83) 3.20 (1.30) 3.40 (1.30)
Yes Mean (SD) 3.2 (0.42) 2.62 (0.52) 2.76 (0.51) 3.52 (0.41) 2.28 (0.65) 4.06 (0.66) 3.43 (0.66) 2.91 (0.86) 3.11 (0.86)
Median (IQR) 3.13 (0.50) 2.50 (0.75) 2.80 (0.50) 3.60 (0.50) 2.40 (1.00) 4.20 (0.60) 3.50 (0.83) 3.00 (1.50) 3.20 (1.50)
* p < .05; ** p < .001; A, T-Student tests; B, Anova; C, Kruskal-Wallis; D,Mann-Whitney U; SD, Standar desviation; IQR, Interquartile range
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OAC treatment adherence but not with TTR [22, 23]. A
2017 study [24] using the SAHLPA scale linked inad-
equate level of HL to greater cognitive impairment and
the need for help to take the treatment properly, but the
multivariate analysis could not correlate an inadequate
level of HL with having a TTR in the range. It is possible
that these studies were unrelated because the scales were
only used to evaluate recognition and ability to read cer-
tain words, not the different dimensions and skills that
comprise HL. Because of this, patients may receive high
scores in the scales yet lack more complex treatment-
focused skills.
With respect to the occurrence of complications asso-
ciated with OAC treatment, our study showed a signifi-
cant association with scores in all HL dimensions, with
higher-scoring patients experiencing fewer complica-
tions, lower emergency department attendance and
hospitalization rates. Complications occurred in 49.2% of
participants (228 patients), well above the 9% shown in a
2014 study [25]. This difference could be due to the ori-
gin of the information about the occurrence of compli-
cations, extracted from medical records in our case,
while the 2014 study [25] used patient-reported compli-
cations which may have been affected by recall bias, par-
ticularly as the study noted that more than 50% of
patients did not recognize emergency situations.
Overall, such results may have been expected as HL
dimensions allow people to identify reliable and accurate
health information, resolve doubts on their own or with
peer support and learn about preventive health services,
anticipating and mitigating the occurrence of complica-
tions. This perspective is also supported by other au-
thors who associate lower HL with a reduced awareness
of AF diagnosis [26], adherence to treatment [20], higher
rates of re-hospitalization [27], risk of mortality [27–29]
and a decrease in physical and emotional health status
[15]. This study [15] also uses the HLQ questionnaire
but only evaluated two dimensions, “Understanding
health information” and “Engaging with healthcare pro-
viders”, and suggests that HL is also associated with
health behaviours in cardiovascular patients.
In addition to the above variables, a relationship be-
tween age, educational or academic level and social class
was also observed with HL scores. Younger patients con-
sidered themselves capable of identifying accurate infor-
mation from different sources, even on their own,
remaining up-to-date and knowledgeable about health
services. These results are consistent with other studies
on patients with cardiovascular health problems, which
negatively correlated the level of HL with the age of the
participants [30–32]. The powerful influence of ‘educa-
tional’ or academic factors on HL, explaining about 60%
of the HL level [31], as well as ‘social class’ has been ex-
tensively described [14, 33, 34]. These findings coincide
with our results where these variables presented signifi-
cance in all dimensions of HL.
Table 4 Statistical relationship between variables related to the treatment of OACs and occurrence of complications with HL
dimensions
D1 D2 D3 D4 D5 D6 D7 D8 D9
Good VKAs control A Sig. < .001** < .001** < .001** .006* < .001** < .001** < .001** < .001** < .001**
No Mean (SD) 3.06 (0.41) 2.37 (0.42) 2.54 (0.50) 3.41 (0.46) 2.02 (0.58) 3.86 (0.60) 3.13 (0.61) 2.45 (0.64) 2.64 (0.67)
Yes Mean (SD) 3.31 (0.41) 2.89 (0.46) 3.04 (0.39) 3.56 (0.40) 2.68 (0.62) 4.30 (0.50) 3.81 (0.52) 3.54 (0.67) 3.77 (0.65)
Adequate frequency A Sig. < .001** < .001** < .001** .001* < .001** < .001** < .001** < .001** < .001**
No Mean (SD) 3.06 (0.37) 2.36 (0.40) 2.50 (0.48) 3.37 (0.45) 1.97 (0.60) 3.86 (0.60) 3.12 (0.61) 2.46 (0.66) 2.66 (0.71)
Yes Mean (SD) 3.28 (0.44) 2.83 (0.50) 3.00 (0.42) 3.56 (0.41) 2.63 (0.60) 4.25 (0.54) 3.74 (0.56) 3.41 (0.74) 3.63 (0.74)
Inform that he takes VKAs D Sig. .027* .004* < .001** .014* .005* .001* .005* < .001** < .001**
No Mean (SD) 3.00 (0.46) 2.32 (0.56) 2.28 (0.53) 3.30 (0.37) 1.99 (0.68) 3.71 (0.70) 3.16 (0.55) 2.33 (0.74) 2.60 (0.88)
Yes Mean (SD) 3.21 (0.41) 2.68 (0.49) 2.86 (0.46) 3.51 (0.43) 2.42 (0.67) 4.15 (0.56) 3.54 (0.63) 3.12 (0.82) 3.40 (0.83)
Complications A Sig. < .001** < .001** < .001** .002* < .001** < .001** < .001** < .001** < .001**
No Mean (SD) 3.31 (0.40) 2.91 (0.44) 3.05 (0.40) 3.57 (0.37) 2.74 (0.59) 4.31 (0.51) 3.85 (0.54) 3.60 (0.66) 3.82 (0.63)
Yes Mean (SD) 3.08 (0.41) 2.38 (0.44) 2.57 (0.49) 3.40 (0.48) 2.02 (0.57) 3.88 (0.59) 3.14 (0.55) 2.48 (0.61) 2.69 (0.68)
Emergency assistance A Sig. < .001** < .001** < .001** .002* < .001** < .001** < .001** < .001** < .001**
No Mean (SD) 3.31 (0.40) 2.91 (0.43) 3.04 (0.40) 3.57 (0.37) 2.74 (0.58) 4.31 (0.51) 3.85 (0.54) 3.60 (0.66) 3.83 (0.63)
Yes Mean (SD) 3.08 (0.42) 2.38 (0.44) 2.57 (0.49) 3.40 (0.48) 2.01 (0.57) 3.88 (0.60) 3.13 (0.54) 2.47 (0.60) 2.67 (0.67)
Hospital admission A Sig. .001* < .001** < .001** .073 < .001** < .001** < .001** < .001** < .001**
No Mean (SD) 3.23 (0.40) 2.70 (0.50) 2.86 (0.48) 3.51 (0.42) 2.44 (0.67) 4.16 (0.55) 3.57 (0.63) 3.15 (0.82) 3.36 (0.83)
Yes Mean (SD) 2.95 (0.54) 2.31 (0.48) 2.43 (0.54) 3.36 (0.47) 1.92 (0.58) 3.68 (0.70) 3.03 (0.57) 2.28 (0.64) 2.52 (0.77)
* p < .05; ** p < .001; A, T-Student tests; B, Anova; C, Kruskal-Wallis; D, Mann-Whitney U
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The health outcomes obtained in our study would
align well with the WHO’s social determinants model,
which proposes the ‘social origin’ of diseases, in turn
causing health inequalities. Within this framework, HL
has shown its central role as a determinant of health
[35]. In fact, low levels of education limit access to better
jobs, or nudging persons towards less secure and riskier
jobs, with lower incomes and poorer levels of health
throughout life [36, 37].
Our research has shown that different health determi-
nants could contribute to inadequate control of anti-
coagulant therapy. Such determinants would be older
age (over 75 years), basic or no education, limited HL
(specifically the HL dimensions “Assessment of health
information”, “Ability to find good health information”
and “Understanding health information sufficiently to
know what to do”), low social class, obesity, multi-
morbidity and polypharmacy. This finding allows an
early identification of a profile of patients, more vulner-
able, who would be most at risk of developing complica-
tions, having worse health outcomes.
Further, our study is a pioneer in evaluating the nine
dimensions that make up HL in patients on VKAs treat-
ment (only one study has been found that evaluated the
HL dimensions in this population and it only assesses
two dimensions) and we noted the importance of the
“social health support” dimension which showed a
higher than expected average score. This dimension as-
sesses a person’s social system and measures the follow-
ing aspects: If I can get access to several people who
understand and support me. If when I feel ill, the people
around me really understand what I am going through.
If I need help, I have plenty of people I can rely on. If I
have at least one person who can come to medical ap-
pointments with me and if I I have strong support from
family or friends.
In our study, this high score could be explained by the
environment in which the study was carried out, a
mainly rural área where inhabitants would benefit more
from social support networks at neighbourhood and
family level, less present or weaker in the urban environ-
ment, as shown in some studies carried out in Spain on
patients with various pathologies [38, 39].
In addition to the novel aspects discussed above, our
work establishes a strong relationship between the di-
mensions of HL and the social determinants that consti-
tute the axes of inequality in health. It highlights the
importance of considering HL as a determinant of health
because it is a predictor of individual health status and
enables people in vulnerable situations to be identified
and health inequalities to be addressed more effectively.
For all these reasons, our study shows how HL inter-
venes in health behaviours and outcomes, modulating
therapeutic concordance and the occurrence of
complications in cardiovascular patients. Furthermore,
taking into account the social determinants that influ-
ence HL, it would be appropriate to establish individual
therapeutic measures and community interventions that
act synergistically in HL to improve the prevention of
cardiovascular disease.
Limitations
The study was conducted only in a rural population set-
ting, using validated questionnaires for Spanish-speaking
people. Routine objective variables have been collected
and the sample size was calculated to reach a represen-
tative sample of the population. Although participation
in the study and completion of the questionnaire was of-
fered to all patients, we were forced to stop the collec-
tion when the representative sample was reached and
this could be interpreted as a selection bias. Further-
more, the study used a bivariate analysis model, so the
results should be taken with caution because the statis-
tical significance could not be demonstrated with vari-
ables tested in more powerful analyses, such as
multivariate models.
Conclusions
The importance of the social environment in the health
and safety outcomes of VKAs treatment is highlighted.
People with higher scores on HL dimensions demon-
strated better therapeutic control, lower emergency de-
partment attendance and fewer hospital admissions,
highlighting the importance of intervening on this deter-
minant because of its consequences on the control of
patients with heart disease requiring VKAs treatment.
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